Singapore - English - HSA (Health Sciences Authority)

roche diagnostics asia pacific pte ltd - microbiology - it is a qualitative in vitro nucleic acid amplification test for the detection of hepatitis c virus (hcv) rna genotypes 1 to 6 in human edta plasma or serum using the cobas® ampliprep instrument for automated specimen processing and the cobas® taqman® analyzer or the cobas® taqman® 48 analyzer for automated amplification and detection. it is indicated for patients who have clinical and/or biochemical evidence of liver disease and antibody evidence of hcv infection, and who are suspected to be actively infected with hcv. the test can be used to confirm antibody positive specimens. detection of hcv rna indicates that the virus is replicating and therefore is evidence of active infection. it is not intended for use as a screening test for the presence of hcv in blood or blood products.

Singapore - English - HSA (Health Sciences Authority)

roche diagnostics asia pacific pte ltd - microbiology - the device is an in vitro nucleic acid amplification test for the quantitation of human immunodeficiency virus type 1 (hiv-1) rna in human edta plasma using the cobas® ampliprep instrument for automated specimen processing and the cobas® taqman® analyzer or cobas® taqman® 48 analyzer for automated amplification and detection. the cobas® ampliprep/cobas® taqman® hiv-1 test, v2.0 is not intended for use as a screening test for the presence of hiv-1 in blood or blood products or as a diagnostic test to confirm the presence of hiv-1 infection. this test is intended for use in conjunction with clinical presentation and other laboratory markers of disease progress for the clinical management of hiv-1 group m and hiv-1 group o infected patients. the test can be used to assess patient prognosis by measuring the baseline hiv-1 rna level or to monitor the effects of antiretroviral therapy by measuring changes in hiv-1 rna levels during the course of antiretroviral treatment.

Singapore - English - HSA (Health Sciences Authority)

roche diagnostics asia pacific pte ltd - microbiology - the cobas taqman hbv test for use with the high pure system (hps) is an in vitro nucleic acid amplification test for the quantitation of hepatitis b virus (hbv) dna in human serum or plasma, using the high pure system viral nucleic acid kit for manual specimen preparation and the cobas taqman 48 analyzer for automated amplification and detection. the cobas taqman hbv test is not intended for use as a screening test for blood or blood products for the presence of hbv or as a diagnostic test to confirm the presence of hbv infection.

Singapore - English - HSA (Health Sciences Authority)

roche diagnostics asia pacific pte ltd - immunology - immunoassay for the in vitro quantitative determination of degradation products of type i collagen in human serum and plasma as an aid in assessing bone resorption. the test may be used as an aid in monitoring antiresorptive therapies in osteoporotic patients. the electrochemiluminescence immunoassay “eclia” is intended for use on cobas e immunoassay analyzers.

Singapore - English - HSA (Health Sciences Authority)

roche diagnostics asia pacific pte ltd - microbiology - the cobas® ampliprep/cobas® taqman® cmv test is an in vitro nucleic acid amplification test for the quantitation of cytomegalovirus dna in edta human plasma using the cobas® ampliprep instrument for automated specimen processing and the cobas® taqman® analyzer or cobas® taqman® 48 analyzer for automated amplification and detection. the test is intended to be used in conjunction with clinical presentation and other laboratory markers in the diagnosis and management of cmv infection in patients at risk for cmv disease. the cobas® ampliprep/cobas® taqman® cmv test is not intended for use as a screening test for the presence of cmv in blood or blood products or as a diagnostic test to confirm the presence of cmv infection. the results from the cobas® ampliprep/cobas® taqman® cmv test must be interpreted within the context of all relevant clinical and laboratory findings.

Singapore - English - HSA (Health Sciences Authority)

roche diagnostics asia pacific pte ltd - pathology - the ventana mmr ihc panel is indicated for the detection of mismatch repair protein deficiency as a test for the identification of individuals at risk for lynch syndrome in patients diagnosed with colorectal cancer (crc), and, with braf v600e status, as an aid to differentiate between sporadic and probable lynch syndrome crc in the absence of mlh1 protein expression. these products should be interpreted by a qualified pathologist in conjunction with histological examination, relevant clinical information, and proper controls.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

eurochem pty. ltd. - nonionic alcohol ethoxylates - liquid - nonionic alcohol ethoxylates active active 1000.0 g/l - wetting agent

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

eurochem pty. ltd. - dodine - suspension concentrate - dodine guanidine active 400.0 g/l - fungicide

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

eurochem pty. ltd. - boscalid - water dispersible granule - boscalid fungicide active 500.0 g/kg - fungicide

Singapore - English - HSA (Health Sciences Authority)

roche diagnostics asia pacific pte ltd - microbiology - cobas® bkv is an in vitro nucleic acid amplification test for the quantitation of bk virus (bkv) dna in human edta plasma and urine stabilized in cobas® pcr media. in edta plasma, cobas® bkv is intended for use as an aid in the diagnosis and management of bkv in transplant patients. in patients undergoing monitoring of bkv in edta plasma, serial dna measurements can be used to indicate the need for potential treatment changes and to assess viral response to treatment. in urine stabilized in cobas® pcr media, cobas® bkv is intended for use as an aid in the diagnosis and management of bkv in transplant patients. the results from cobas® bkv must be interpreted within the context of all relevant clinical and laboratory findings. cobas® bkv is not intended for use as a screening test for blood or blood products.